Aims a) To identify which pretreatment clinical or blood parameters were predictive of patient
survival in small-cell lung cancer (SCLC) in a retrospective analysis. b) To validate three …

In 407 patients with small‐cell lung cancer (SCLC), 61 pretreatment variables were
evaluated in a Cox multiple regression analysis to assess their prognostic value. All patients …

We have evaluated the prognostic value of 22 pretreatment attributes in 436 small cell lung
cancer (SCLC) patients included in a prospective multicenter study with a minimum 5-year …

The aims of this study were to identify prognostic factors in patients (pts) with small cell lung
cancer and to identify dominant prognostic factors independent of disease stage, to define …

Based on an increased frequency of early death (death within the first treatment cycle) in our
two latest randomized trials of combination chemotherapy in small-cell lung cancer (SCLC) …

Several studies of small cell lung cancer (SCLC) treatments have been performed in the
United Kingdom. In some, prognostic factor analyses were carried out but the results were …

An analysis of prognostic factors in small cell lung cancer has been carried out using data
from 371 patients treated with identical chemotherapy in the context of a large prospectively …

Clinical and laboratory parameters can predict response to chemotherapy and long term
survival in small cell lung cancer, and may predict those at risk of early treatment related …

The relationships between prognostic factors and duration of survival in small cell lung
cancer were investigated in a consecutive series of 874 patients treated with combination …

BACKGROUND: An analysis of 14 small cell lung cancer (SCLC) trials was performed to
improve the current understanding of potential prognostic factors for overall survival (OS) …